Anibal S Chertcoff
7PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Nov 03, 2025
Safety reporting quality in multiple sclerosis clinical trials: A review of phase III clinical trials included in FDA approval of disease-modifying treatments.William Z Lin, Jaimie J Lee, Anibal Chertcoff
|Oct 27, 2025
Psychiatric morbidity during the multiple sclerosis prodrome is associated with future disability.Anibal S Chertcoff, Marta Ruiz-Algueró, Fardowsa Yusuf
|Sep 25, 2023
Psychiatric Comorbidity During the Prodromal Period in Patients With Multiple Sclerosis.Anibal S Chertcoff, Fardowsa L A Yusuf, Feng Zhu
|Oct 27, 2022
Polypharmacy and multiple sclerosis: A population-based study.Anibal Chertcoff, Huah Shin Ng, Feng Zhu
|Dec 06, 2021
Evaluation of short-term safety of COVID-19 vaccines in patients with multiple sclerosis from Latin America.Ricardo Alonso, Aníbal Chertcoff, Felisa Del V Leguizamón
|Aug 26, 2021
Assessing attacks and treatment response rates among adult patients with NMOSD and MOGAD: Data from a nationwide registry in Argentina.Edgar Carnero Contentti, Pablo A Lopez, Juan Pablo Pettinicchi
Pageof 2
Frequent Collaborators
4 joint publications
Helen Tremlett
3 joint publications
Ricardo Alonso
2 joint publications
Berenice Silva
2 joint publications
María Barbara Eizaguirre
1 joint publications
Edgar Carnero Contentti
1 joint publications
Mariano Marrodan
1 joint publications
Geraldine Luetic
1 joint publications
Adriana Carrá
1 joint publications
Huah Shin Ng
1 joint publications
William Z Lin
